GL1X · GenesisL1 explorer

Research workbench

Structural analysis of dfg-in and dfg-out dual src-abl inhibitors sharing a common vinyl purine template

Analyse Structural analysis of dfg-in and dfg-out dual src-abl inhibitors sharing a… in the GL1X research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides, crosslinks and neighbours on the 3D structure.

PDB
3KFA
Type
protein
Length
568 residues
Chains
2
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Tyrosine-protein kinase ABL1
EC
2.7.10.2
UniProt
P00520
Ligands
B91
Pockets
7 · best druggability 0.75

Structure

x-ray diffraction · 1 distinct chain · 46% helix, 17% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
A, BTyrosine-protein kinase ABL1 (EC 2.7.10.2)protein28446% helix, 17% strandP00520

Ligands and binding sites

  • B91 · 3-{(E)-2-[6-(cyclopropylamino)-9H-purin-9-yl]ethenyl}-4-methyl-N-[3-(4-methyl-1H-imidazol-1-yl)-5-(trifluoromethyl)phenyl]benzamide · ligand · 2 copies · chains A, B

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

7 pockets found on a 1 Å grid, 2 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
16470.750.8166B91
26200.730.8059B91
3880.470.8118empty
4520.460.8415empty
52070.460.7425empty

Interfaces

1 interface between chains.

  • A–B · 317 Ų buried · 5 hydrogen bonds · protein-protein

Compared structures

  • 3KFA · Structural analysis of DFG-in and DFG-out dual Src-Abl inhibitors sharing a common vinyl… · the same entry in another collection · chain A against A, TM-score 1.00
  • P00520 · AlphaFold monomer V2.0 prediction for tyrosine-protein kinase ABL1 (P00520) · a predicted model of the same protein · chain B against A, TM-score 0.87

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.